HIF1A and cancer: Increased expression of miRNA-210, -31 and -378, which specifically target SDH mRNA, was reported in cancer cells after radiotherapy [75]; miR-210 was also highly expressed at a late stage of lung cancer, and targeted SDHD resulting in significant alterations in cell metabolism and survival in addition to increased hypoxia-inducible factor1 (HIF1) activity [76].